URIROX Trademark

Trademark Overview

On Wednesday, September 9, 2020, a trademark application was filed for URIROX with the United States Patent and Trademark Office. The USPTO has given the URIROX trademark a serial number of 90169538. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 20, 2023. This trademark is owned by Allena Pharmaceuticals, Inc.. The URIROX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of hyperoxaluria, metabolic disorders, kidney disease, oxalate nephropathy, diabetic nephropathy, hyperoxalemia, oxalosis and diseases in which oxalate levels are elevated
urirox

General Information

Serial Number90169538
Word MarkURIROX
Filing DateWednesday, September 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of hyperoxaluria, metabolic disorders, kidney disease, oxalate nephropathy, diabetic nephropathy, hyperoxalemia, oxalosis and diseases in which oxalate levels are elevated

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSudbury, MA 01776
Party NameAllena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02462

Trademark Events

Event DateEvent Description
Monday, November 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023SOU EXTENSION 4 GRANTED
Wednesday, April 19, 2023SOU EXTENSION 4 FILED
Wednesday, April 19, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2022SOU EXTENSION 3 GRANTED
Wednesday, October 5, 2022SOU EXTENSION 3 FILED
Wednesday, October 5, 2022SOU TEAS EXTENSION RECEIVED
Saturday, March 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 17, 2022SOU EXTENSION 2 GRANTED
Thursday, March 17, 2022SOU EXTENSION 2 FILED
Thursday, March 17, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 1 GRANTED
Tuesday, October 19, 2021SOU EXTENSION 1 FILED
Tuesday, October 19, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 15, 2021ASSIGNED TO EXAMINER
Thursday, October 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 12, 2020NEW APPLICATION ENTERED

Related Keywords

urirox nephropathy oxalate oxalosis hyperoxalemia diseases which elevated levels diabetic preparations